期刊文献+

喉咽癌组织中胰岛素生长因子1受体与尿激酶型纤溶酶原激活剂的表达及意义 被引量:1

Expression of IGF-1R and u-PALI in the laryngopharynx carcinoma
下载PDF
导出
摘要 目的探讨胰岛素生长因子1受体(IGF-1R)与尿激酶型纤溶酶原激活剂(u—PA)在喉咽癌中的表达及其相互关系。方法采用免疫组织化学链霉菌抗生物素蛋白-过氧化物酶连结法(SP法),分别检测55例喉咽癌(咽喉癌组)、42例癌旁喉咽黏膜(癌旁组)及40例会厌囊肿(对照组)中IGF-1R蛋白和u-PA蛋白的表达情况。结果①IGF-1R与尿激酶型纤溶酶原激活剂u—PA在喉咽癌组、癌旁组及对照组中的阳性表达率及强阳性率依次降低(81.82%,52.38%,17.50%),3组间两两比较,差异均有统计学意义(P〈0.01);②IGF-1R与U-PA在喉咽癌有淋巴结转移组的强阳性表达率分别为82.61%和78.26%,与无淋巴结转移组中22.22%和44.44%相比,差异有统计学意义(P〈0.01或P〈0.05)。③IGF-1R与u-PA在喉咽癌组织中的表达有明显的相关性(P〈0.01)。结论①IGF-1R和u—PA在喉咽癌组织中高表达可能与喉咽癌的发生发展有关。②检测喉咽癌组织中IGF-1R和u—PA的表达,可能有助于估计喉咽癌淋巴结转移。③IGF-1R与u—PA可能在喉咽癌发生、发展以及淋巴结转移中起了协同作用。 Objective To investigate the expressions of IGF-1R protein and u-PA protein in the tissue of laryngopharynx carcinoma and to discuss the mechanism of pathogenesis, development, invasion and metastasis of laryngopharynx carcinoma. Methods IGF-1R protein and u-PA protein were detected by immunohistichemistry SP method in 55 laryngopharynx carcinoma cases, 42 adjacent to cancer cases and 40 epiglottis cyst cases. Results ①The positive expressions of IGF-1R and u-PA protein in the tissue of laryngopharynx carcinoma, in the tissue adjacent to cancer and in the tissue of epiglottis cyst was decreased sequentially with significant differences ( P 〈 0.01 ).②The positive expressions of IGF-1R and u-PA protein in the tissue of metastasis and non-metastasis showed statisti- cal difference( P 〈0.01 ). ③The IGF-1R expression was closely correlated with the u-PA expression (P 〈 0.01). Conclusion ①IGF-1R and u-PA are related to the pathogenesis and development of laryngopharynx carcinoma.②Detection of IGF-1R and u-PA in the tissue of laryngopharynx carcinoma might help evaluate the lymphatic metastasis of laryngopharynx carcinoma.
出处 《中国医药》 2009年第8期592-594,共3页 China Medicine
关键词 咽喉肿瘤 胰岛素生长因子1受体 尿激酶型纤溶酶原激活剂 免疫组化 Laryngopharynx carcinoma Insulin-like growth factor-1 receptor Urokinase type plasminogen activator Immunohistochemistry
  • 相关文献

同被引文献10

  • 1陈自平,刘倩,徐昌青,王文奇,贾欣永.胰岛素样生长因子Ⅱ及其受体在胃癌组织中的表达及意义[J].中国肿瘤临床,2005,32(23):1338-1341. 被引量:8
  • 2张平,许成蓉.胰岛素样生长因子I受体与抗肿瘤治疗[J].现代肿瘤医学,2006,14(3):360-362. 被引量:7
  • 3Roche P,Brown J,Denley A,et al.Computational model for the IGFⅡ/IGF2r complex that is predictive of mutational and surface plasmon resonance data[J].Proteins,2006,64(3):758-768.
  • 4Lu L,Katsaros D,Wiley A,et al.The relationship of insulin-like growth fnctor-Ⅱ,insulin-like growth factor binding protein-3,and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer[J].Clin Cancer Res,2006,12(4):1208-1214.
  • 5Deming SL,Ben Z,Cai Q,et al.IGF-Ⅰ and IGF-Ⅱ genetic variation and breast cancer risk in Chinese women:results from the Shanghai Breast Cancer Study[J].Cancer Epidemiol Biomarkers Prey,2008,17(1):255-257.
  • 6Baron-Hay S,Boyle F,Ferrier A,et al.Elevated serum insulin-like growth factor binding protein-2 as a prognostic marker in patients with ovarian cancer[J].Clin Cancer Res,2004,10(5):1796-1806.
  • 7Olchovsky D,Shimon I,Goldberg I,et al.Elevated insulin-like growth factor-1 and insulin-like growth factor binding protein-2 in malignant pleural effusion[J].Acta Oncol,2002,41(2):182-187.
  • 8Sakatani T,Kaneda A,Iacobuzio-Donahue CA,et al.Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice[J].Science,2005,307(5717):1976-1978.
  • 9Sayer RA,Lancaster JM,Pittman J,et al.High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer[J].Gynecol Oncol,2005,96(2):355-361.
  • 10张锋锐,何小兵,杨玉华,谢维.大肠癌中胰岛素样生长因子2基因的印迹状态和表达[J].中华医学遗传学杂志,2003,20(1):31-34. 被引量:16

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部